Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.14%1.41B | -0.47%1.38B | -1.45%1.34B | 3.76%5.64B | -0.39%1.5B | -1.82%1.39B | -0.83%1.39B | 22.16%1.36B | 19.91%5.43B | 26.99%1.5B |
| Operating revenue | 1.23%1.31B | 0.83%1.29B | -0.42%1.26B | 4.62%5.27B | 2.60%1.43B | -1.31%1.3B | -1.70%1.28B | 23.00%1.26B | 22.39%5.04B | 29.82%1.4B |
| Cost of revenue | -0.55%597.2M | 0.71%578.9M | -2.91%596.2M | 3.19%2.52B | -1.58%729.5M | -1.35%600.5M | -3.36%574.8M | 23.74%614.1M | 28.44%2.44B | 42.43%741.2M |
| Gross profit | 2.42%808.3M | -1.31%801.5M | -0.24%746.9M | 4.22%3.12B | 0.77%769.5M | -2.17%789.2M | 1.05%812.1M | 20.89%748.7M | 13.75%2.99B | 14.90%763.6M |
| Operating expense | -7.99%393.8M | -3.44%410.2M | -3.01%412.6M | 1.85%1.7B | -2.84%417.1M | 1.64%428M | -5.41%424.8M | 16.55%425.4M | 13.65%1.66B | 15.56%429.3M |
| Selling and administrative expenses | -7.64%180.2M | 4.91%196.4M | 4.28%197.3M | -0.46%752M | -8.93%180.5M | 7.02%195.1M | -5.69%187.2M | 7.20%189.2M | 8.41%755.5M | 9.14%198.2M |
| -General and administrative expense | -7.64%180.2M | 4.91%196.4M | 4.28%197.3M | -0.46%752M | -8.93%180.5M | 7.02%195.1M | -5.69%187.2M | 7.20%189.2M | 8.41%755.5M | 9.14%198.2M |
| Depreciation amortization depletion | -8.29%213.6M | -10.02%213.8M | -8.85%215.3M | 3.77%943.3M | 2.38%236.6M | -2.47%232.9M | -5.19%237.6M | 25.31%236.2M | 18.41%909M | 21.70%231.1M |
| -Depreciation and amortization | -8.29%213.6M | -10.02%213.8M | -8.85%215.3M | 3.77%943.3M | 2.38%236.6M | -2.47%232.9M | -5.19%237.6M | 25.31%236.2M | 18.41%909M | 21.70%231.1M |
| Operating profit | 14.76%414.5M | 1.03%391.3M | 3.40%334.3M | 7.18%1.42B | 5.41%352.4M | -6.33%361.2M | 9.22%387.3M | 27.13%323.3M | 13.88%1.33B | 14.06%334.3M |
| Net non-operating interest income (expenses) | 16.65%-84.1M | 17.10%-89.2M | 14.73%-91.5M | -0.17%-409.5M | 13.56%-93.7M | 7.26%-100.9M | 5.86%-107.6M | -38.81%-107.3M | -27.55%-408.8M | -37.56%-108.4M |
| Non-operating interest expense | -16.53%81.3M | -14.73%87.4M | -14.06%88.6M | -0.10%396.2M | -11.41%93.2M | -7.15%97.4M | -8.32%102.5M | 38.02%103.1M | 24.99%396.6M | 29.72%105.2M |
| Total other finance cost | -20.00%2.8M | -64.71%1.8M | -30.95%2.9M | 9.02%13.3M | -84.38%500K | -10.26%3.5M | 104.00%5.1M | 61.54%4.2M | 281.25%12.2M | 239.13%3.2M |
| Other net income (expenses) | -85.42%-8.9M | -500.00%-10.8M | -61.67%2.3M | 71.05%-16.5M | 48.38%-15.9M | -300.00%-4.8M | 83.78%-1.8M | 134.29%6M | -57.46%-57M | -38.12%-30.8M |
| Gain on sale of security | -400.00%-900K | -38.46%3.2M | -112.20%-1M | 336.96%10.9M | 61.64%-2.8M | -97.58%300K | 136.36%5.2M | 168.91%8.2M | 78.80%-4.6M | 57.31%-7.3M |
| Special income (charges) | -39.66%-8.1M | -12.68%-16M | 250.00%3.3M | 47.71%-27.4M | 80.43%-4.6M | 42.00%-5.8M | -6.77%-14.2M | 60.71%-2.2M | -261.38%-52.4M | -351.92%-23.5M |
| -Less:Restructuring and mergern&acquisition | 2.27%4.5M | 50.00%8.1M | -250.00%-3.3M | -86.35%6.1M | -120.59%-4.9M | 120.00%4.4M | -59.40%5.4M | -60.71%2.2M | 208.28%44.7M | 197.50%23.8M |
| -Less:Impairment of capital assets | ---- | -88.75%900K | ---- | 176.62%21.3M | ---- | ---- | --8M | ---- | --7.7M | ---- |
| -Less:Other special charges | ---- | 775.00%7M | ---- | ---- | ---- | ---- | --800K | ---- | ---- | ---- |
| -Less:Write off | 157.14%3.6M | ---- | ---- | ---- | ---- | 366.67%1.4M | ---- | ---- | ---- | ---- |
| Income before tax | 25.83%321.5M | 4.82%291.3M | 10.41%245.1M | 15.67%998.2M | 24.45%242.8M | -8.49%255.5M | 21.25%277.9M | 39.18%222M | 6.53%863M | 1.61%195.1M |
| Income tax | 26.22%82.8M | 5.33%75.1M | 11.76%60.8M | 12.64%256.7M | 21.34%65.4M | -6.42%65.6M | 23.14%71.3M | 18.26%54.4M | 6.79%227.9M | 8.89%53.9M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 25.70%238.7M | 4.65%216.2M | 9.96%184.3M | 16.75%741.5M | 25.64%177.4M | -9.18%189.9M | 20.61%206.6M | 47.67%167.6M | 6.44%635.1M | -0.91%141.2M |
| Net income continuous operations | 25.70%238.7M | 4.65%216.2M | 9.96%184.3M | 16.75%741.5M | 25.64%177.4M | -9.18%189.9M | 20.61%206.6M | 47.67%167.6M | 6.44%635.1M | -0.91%141.2M |
| Noncontrolling interests | 188.89%2.6M | -50.00%-1.5M | -14.29%-6.4M | 61.04%-6M | 94.00%-300K | 550.00%900K | 64.29%-1M | 24.32%-5.6M | -413.33%-15.4M | -5M |
| Net income attributable to the company | 24.92%236.1M | 4.87%217.7M | 10.10%190.7M | 14.91%747.5M | 21.55%177.7M | -9.70%189M | 19.24%207.6M | 43.26%173.2M | 8.47%650.5M | 2.60%146.2M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 24.92%236.1M | 4.87%217.7M | 10.10%190.7M | 14.91%747.5M | 21.55%177.7M | -9.70%189M | 19.24%207.6M | 43.26%173.2M | 8.47%650.5M | 2.60%146.2M |
| Diluted earnings per share | 27.16%1.03 | 5.56%0.95 | 9.33%0.82 | 14.54%3.23 | 18.75%0.76 | -10.99%0.81 | 20.00%0.9 | 44.23%0.75 | 10.59%2.82 | 3.23%0.64 |
| Basic earnings per share | 25.93%1.02 | 4.44%0.94 | 17.14%0.82 | 15.36%3.23 | 18.75%0.76 | -3.57%0.81 | 23.29%0.9 | 34.62%0.7 | 9.80%2.8 | 3.23%0.64 |
| Dividend per share | 7.69%0.35 | 7.69%0.35 | 7.69%0.35 | 8.33%1.3 | 8.33%0.325 | 8.33%0.325 | 8.33%0.325 | 8.33%0.325 | 0.00%1.2 | 0.00%0.3 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.